395 related articles for article (PubMed ID: 10706459)
1. Treatment of hairy cell leukemia-variant with cladribine.
Tetreault SA; Robbins BA; Saven A
Leuk Lymphoma; 1999 Oct; 35(3-4):347-54. PubMed ID: 10706459
[TBL] [Abstract][Full Text] [Related]
2. 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland.
Robak T; Błasińska-Morawiec M; Błoński J; Hellmann A; Hałaburda K; Konopka L; Kotlarek-Haus S; Potoczek S; Hansz J; Dmoszyńska A; Urasiński I; Zdziarska B; Dwilewicz-Trojaczek J; Hołowiecki J; Skotnicki AB
Eur J Haematol; 1999 Jan; 62(1):49-56. PubMed ID: 9918312
[TBL] [Abstract][Full Text] [Related]
3. Phase II clinical study of cladribine in the treatment of hairy cell leukemia.
Machii T; Chou T; Suzuki M; Ohe Y; Katagiri S; Kitano EK; Kitano K; Fujiyama Y; Izumi T; Shimazaki C; Nanba K; Ohashi Y; Kitani T;
Int J Hematol; 2005 Oct; 82(3):230-5. PubMed ID: 16207596
[TBL] [Abstract][Full Text] [Related]
4. [Clinical and molecular characteristics and prognosis of classical hairy cell leukemia and hairy cell leukemia variant].
Wei C; Jin XX; Cai H; Wang X; Zhuang JL; Zhou DB
Zhonghua Nei Ke Za Zhi; 2023 Apr; 62(4):416-421. PubMed ID: 37032137
[No Abstract] [Full Text] [Related]
5. [Hairy cell leukemia complicated by bone marrow necrosis following cladribine administration].
Terao T; Yuda J; Yamauchi N; Miyamoto K; Minami M; Kojima M; Sugano M; Kuwata T; Minami Y
Rinsho Ketsueki; 2019; 60(6):559-564. PubMed ID: 31281144
[TBL] [Abstract][Full Text] [Related]
6. Extended follow-up of patients with hairy cell leukemia after treatment with cladribine.
Goodman GR; Burian C; Koziol JA; Saven A
J Clin Oncol; 2003 Mar; 21(5):891-6. PubMed ID: 12610190
[TBL] [Abstract][Full Text] [Related]
7. Cladribine in the treatment of hairy cell leukemia: initial and subsequent results.
Huynh E; Sigal D; Saven A
Leuk Lymphoma; 2009 Oct; 50 Suppl 1():12-7. PubMed ID: 19814692
[TBL] [Abstract][Full Text] [Related]
8. [Successful use of cladribine in the treatment of an elderly woman with typical hairy cell leukemia].
Terasaki Y; Okumura H; Hirose A; Ishiura Y; Yokawa S; Saito K; Nakao S
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1885-8. PubMed ID: 18030031
[TBL] [Abstract][Full Text] [Related]
9. Combined treatment with splenectomy and cladribine in hairy cell leukemia in Taiwan: a clinicopathologic study of 5 cases.
Yu YB; Li CY; Chen CC; You JY; Chau WK; Hsu HC; Gau JP; Chen PM; Ho CH
J Chin Med Assoc; 2007 Dec; 70(12):551-5. PubMed ID: 18194897
[TBL] [Abstract][Full Text] [Related]
10. [Hairy cell leukemia and pregnancy].
Al-Radi LS; Moiseeva TN; Smirnova SY; Shmakov RG
Ter Arkh; 2017; 89(7):99-104. PubMed ID: 28766548
[TBL] [Abstract][Full Text] [Related]
11. Treatment of hairy cell leukemia with cladribine (2-chlorodeoxyadenosine).
Füreder W; Weltermann A; Chott A; Gisslinger H; Valent P; Jäger U; Geissler K; Lechner K
Wien Klin Wochenschr; 1999 Dec; 111(24):1027-30. PubMed ID: 10677889
[TBL] [Abstract][Full Text] [Related]
12. The diagnosis of hairy cell leukemia can be established by flow cytometric analysis of peripheral blood, even in patients with low levels of circulating malignant cells.
Cornfield DB; Mitchell Nelson DM; Rimsza LM; Moller-Patti D; Braylan RC
Am J Hematol; 2001 Aug; 67(4):223-6. PubMed ID: 11443633
[TBL] [Abstract][Full Text] [Related]
13. Rituximab in the treatment of the variant of hairy cell leukaemia: a case report.
Hadzi-Pecova L; Stojanovik A; Petrusevska G; Panovska I
Prilozi; 2008 Dec; 29(2):355-60. PubMed ID: 19259059
[TBL] [Abstract][Full Text] [Related]
14. My treatment approach to hairy cell leukemia.
Naik RR; Saven A
Mayo Clin Proc; 2012 Jan; 87(1):67-76. PubMed ID: 22212971
[TBL] [Abstract][Full Text] [Related]
15. 2-chlorodeoxyadenosine (2-CdA) in 2-hour versus 24-hour intravenous infusion in the treatment of patients with hairy cell leukemia.
Robak T; Błasińska-Morawiec M; Krykowski E; Hansz J; Komarnicki M; Kazimierczak M; Konopka L; Maj S; Hellmann A; Zaucha JM; Urasiński L; Zdziarska B; Kotlarek-Haus S; Usnarska-Zubkiewicz L; Kuratowska Z; Dwilewicz-Trojaczek J; Hołowiecki J; Krawczyk-Kulis M; Grieb P
Leuk Lymphoma; 1996 Jun; 22(1-2):107-11. PubMed ID: 8724536
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of patients with hairy cell leukemia after cladribine treatment.
Saven A; Burian C; Koziol JA; Piro LD
Blood; 1998 Sep; 92(6):1918-26. PubMed ID: 9731048
[TBL] [Abstract][Full Text] [Related]
17. Real-world data on diagnostics, treatment and outcomes of patients with hairy cell leukemia: The HCL-CLLEAR study.
Panovská A; Žák P; Jurková T; Arpáš T; Brychtová Y; Vašíková A; Hrabčáková V; Prchlíková A; Filipová M; Doubek M
Hematol Oncol; 2024 May; 42(3):e3280. PubMed ID: 38741354
[TBL] [Abstract][Full Text] [Related]
18. The variant form of hairy-cell leukaemia.
Matutes E; Wotherspoon A; Catovsky D
Best Pract Res Clin Haematol; 2003 Mar; 16(1):41-56. PubMed ID: 12670464
[TBL] [Abstract][Full Text] [Related]
19. A single cycle of 2-chlorodeoxyadenosine results in complete remission in the majority of patients with hairy cell leukemia.
Tallman MS; Hakimian D; Variakojis D; Koslow D; Sisney GA; Rademaker AW; Rose E; Kaul K
Blood; 1992 Nov; 80(9):2203-9. PubMed ID: 1358262
[TBL] [Abstract][Full Text] [Related]
20. Long-term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trial.
Chihara D; Kantarjian H; O'Brien S; Jorgensen J; Pierce S; Faderl S; Ferrajoli A; Poku R; Jain P; Thompson P; Brandt M; Luthra R; Burger J; Keating M; Ravandi F
Br J Haematol; 2016 Sep; 174(5):760-6. PubMed ID: 27301277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
